Suchergebnisse - "Pruijssers, Andrea J"

PubPharm (7)

1

Evaluation of in vitro antiviral activity of SARS-CoV-2 Mpro inhibitor pomotrelvir and cross-resistance to nirmatrelvir resistance substitutions

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Tong, X. | Keung, W. | Arnold, L. | +6

2

A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance

enthalten in: mBio | 2023

von Grimes, S. | Choi, Y. | Banerjee, A. | +10

3

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

enthalten in: Science translational medicine | 2022

von Stevens, L. | Pruijssers, A. | Lee, H. | +14

4

The coronavirus proofreading exoribonuclease mediates extensive viral recombination

enthalten in: PLoS pathogens | 2021

von Gribble, J. | Stevens, L. | Agostini, M. | +6

5

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

enthalten in: Science translational medicine | 2020

von Sheahan, T. | Sims, A. | Zhou, S. | +25

6

Small-Molecule Antiviral β-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance

enthalten in: Journal of virology | 2019

von Agostini, M. | Pruijssers, A. | Chappell, J. | +13

7

Nucleoside analogues for the treatment of coronavirus infections

enthalten in: Current opinion in virology | 2019

von Pruijssers, A. | Denison, M.

1
[1]